EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
News
/
News and information
/
Kexing Biopharm...
Kexing Biopharm's Product Introduction
Article source:Kexing Biopharm
Jun 17,2025
View: 1704
LABEL:
< Kexing Biopharm's Product List (FDA and EMA Approved)
Kexing Biopharm's Product Catalog (Core Product) >
BACK TO LIST
Related News
Sep 20,2023
Exploring the Power of Albumin-Bound Paclitaxel: A Breakthrough in Cancer Treatment
READ MORE >>
Jul 13,2023
Kexing Biopharm won the sole agency for the first-time generic drug of infliximab, demonstrating strong superiority in ...
READ MORE >>
Jul 13,2023
Kexing Biopharm obtained the products of Trastuzumab and Neratinib Maleate Tablets
READ MORE >>
Nov 04,2024
Harnessing the Power of Recombinant Collagen Repair Mask for Youthful Skin
READ MORE >>
Dec 06,2023
Unlocking the Power of Human Interferon α1b for Injection: A Breakthrough in Immunotherapy
READ MORE >>
Oct 11,2023
Unveiling the Power of Human Granulocyte Colony Stimulating Factor Injections: Boosting Immune System Health and Recovery
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium and Bifidobacterium,Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and information
Video Center
Contact
Contact Us
Join Us